Clinical Trials
Passion and Understanding Essential for Rare Disease Clinical Trials
Juliet Moritz
Ergomed
PAO-10-24-CL-03Oct 29, 2024
Biologics
Chime Biologics and MedPacto Form Strategic Partnership to Accelerate Global Biologics Development and Manufacturing
Chime Biologics
PR-10-24-NI-66Oct 29, 2024
Financing
AbbVie to Acquire Aliada Therapeutics, Strengthening Focus in Alzheimer's Disease and Neuroscience Pipeline
AbbVie
PR-10-24-NI-65Oct 29, 2024
Clinical Trials
TREMFYA is the first and only IL-23 inhibitor to demonstrate robust results with regimen in both induction and maintenance
Johnson & Johnson
PR-10-24-NI-64Oct 28, 2024
Clinical Trial
Abbott Initiates New Clinical Trial to Improve Outcomes in Patients with Advanced Heart Failure
Abbott
PR-10-24-NI-61Oct 25, 2024
Clinical Development
Children's Hospital of Philadelphia Researchers Find Promising New Immunotherapy Target in Neuroblastoma and Other Cancers
Children's Hospital of Philadelphia
PR-10-24-NI-60Oct 25, 2024
Advanced Therapies
A New Vision for Progressing Advanced Therapies
Nathaniel Youndt
ReciBioPharm
PAO-10-24-CL-13Oct 25, 2024
Clinical Development
Dotmatics Introduces Luma Antibody & Protein Engineering Solution for End-to-End Antibody Discovery
Dotmatics
PR-10-24-NI-57Oct 22, 2024
Clinical Research
Tc Biopharm
TC Biopharm
PR-10-24-NI-55Oct 22, 2024
Oncology Trials
Navigating the Complex Landscape of Oncology Trials
Colin Hayward, MB BS
Ergomed
PAO-10-24-CL-04Oct 22, 2024
Clinical Trials
INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP
Inovio Pharmaceuticals, Inc.
PR-10-24-NI-53Oct 21, 2024
Biopharma
Life Sciences and Cryoport Form Partnership to Elevate Standards for Frozen Egg, Embryo, etc Offsite Storage and Biologistics
Cryoport
PR-10-24-NI-52Oct 21, 2024
Clinical Development
MOBILion Systems Unveils Novel High Resolution Mass Spectrometry Functionality for Proteomics Workflows
MOBILion Systems, Inc.
PR-10-24-NI-51Oct 21, 2024
Financing
mRNA Synthesis & Manufacturing Market to Hit USD 738.3 Million by 2029 with 3.4% CAGR | MarketsandMarkets™
MarketsandMarkets™
PR-10-24-NI-50Oct 17, 2024
Clinical Trials
Update on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial
Novavax
PR-10-24-NI-48Oct 17, 2024
Clinical Trials
Triumvira Immunologics Announces Publication Demonstrating the Safety and Efficacy of TAC T Cells Targeting Claudin 18.2
Triumvira Immunologics Inc.
PR-10-24-NI-47Oct 16, 2024
MDD
Firefly Neuroscience Announces Use of Its Brain Network Analytics Platform in Phase 1 Study for Major Depressive Disorder
Firefly Neuroscience
PR-10-24-NI-46Oct 16, 2024
Clinical Trials
Harbour BioMed Announces the Phase I Study Results in Combination with Toripalimab in Advanced Melanoma and Other Solid Tumors
Harbour BioMed
PR-10-24-NI-39Oct 11, 2024
Clinical Trials
StemCyte's HPC Cord Blood Receives RMAT Designation for Long COVID-19 Treatment
StemCyte
PR-09-24-NI-28Oct 07, 2024
Clinical Trials
Soligenix Announces Partnership with Sterling Pharma Solutions
Soligenix, Inc.
PR-09-24-NI-32Oct 07, 2024